The analyst placed a 12–18-month price target of $32 on ALMS. The Price Action of ALMS In the last month, the shares have ...

In this article, we are going to take a look at where Alumis Inc. (NASDAQ:ALMS) stands against other Thursday’s worst-performing stocks. Wall Street’s main indices edged lower on Thursday ...

The latest price target for Alumis (NASDAQ:ALMS) was reported by Guggenheim on June 10, 2025. The analyst firm set a price target for $18.00 expecting ALMS to rise to within 12 months (a possible ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Alumis Inc. (NASDAQ: ALMS) and ACELYRIN, INC. is fair to Alumis shareholders.

Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform rating. Why Oppenheimer Is Bullish on ALMS Due to concerns about Alumis ...